Position in TAK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$48,199,096
-$18,740,466 QoQ
Shares Held
2,602,543
-39.4% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Derivatives in TAK
reported options exposure · as of Dec 31, 2020CallValue
$273,000
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in TAK
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,199,096 | 2,602,543 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $66,939,562 | 4,293,750 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,118,144 | 281,294 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $833,255 | 56,036 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,739,873 | 122,354 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $4,921,213 | 354,299 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,067,436 | 214,957 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,144,335 | 267,895 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,510,639 | 287,119 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,763,622 | 410,414 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $3,404,236 | 237,726 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,593,938 | 190,311 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $273,000 | 15,000 | Call | Defined | 2021-02-16 | |
| 2020-09-30 | $267,600 | 15,000 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $268,950 | 15,000 | Call | Defined | 2020-08-14 | |
| 2020-03-31 | $3,037,214 | 200,080 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||